Yang Lv

436 total citations
24 papers, 312 citations indexed

About

Yang Lv is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yang Lv has authored 24 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yang Lv's work include Neuroendocrine Tumor Research Advances (6 papers), Ferroptosis and cancer prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Yang Lv is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Ferroptosis and cancer prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Yang Lv collaborates with scholars based in China, Ethiopia and United States. Yang Lv's co-authors include Qingyang Feng, Guodong He, Xuefeng Xu, Zhiyuan Zhang, Jianmin Xu, Yuqiu Xu, Yihao Mao, Xu Han, Dansong Wang and Meiling Ji and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Frontiers in Immunology.

In The Last Decade

Yang Lv

24 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Lv China 12 189 98 91 80 76 24 312
Valeria Smiroldo Italy 10 199 1.1× 70 0.7× 58 0.6× 85 1.1× 45 0.6× 28 280
Shuichi Tsukamoto Japan 11 132 0.7× 107 1.1× 58 0.6× 106 1.3× 48 0.6× 23 333
Isabella Bergagnini United States 8 191 1.0× 134 1.4× 50 0.5× 179 2.2× 79 1.0× 18 379
Hirofumi Rokutan Japan 10 144 0.8× 170 1.7× 74 0.8× 120 1.5× 48 0.6× 24 370
Ryo Muranushi Japan 12 203 1.1× 60 0.6× 95 1.0× 52 0.7× 35 0.5× 41 341
Chenghao Yi China 9 216 1.1× 83 0.8× 61 0.7× 64 0.8× 125 1.6× 16 362
Akira Okimura Japan 8 141 0.7× 112 1.1× 27 0.3× 82 1.0× 49 0.6× 28 290
Fenglong Bie China 13 211 1.1× 143 1.5× 66 0.7× 155 1.9× 88 1.2× 32 429
J.C. Ruffinelli Spain 9 180 1.0× 90 0.9× 23 0.3× 102 1.3× 45 0.6× 27 271

Countries citing papers authored by Yang Lv

Since Specialization
Citations

This map shows the geographic impact of Yang Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Lv more than expected).

Fields of papers citing papers by Yang Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Lv. The network helps show where Yang Lv may publish in the future.

Co-authorship network of co-authors of Yang Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Lv. A scholar is included among the top collaborators of Yang Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Lv. Yang Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Yang, Peng Zheng, Yihao Mao, et al.. (2023). Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. Cancer Science. 115(1). 257–269. 7 indexed citations
2.
Lv, Yang, Zhiyuan Zhang, Qi Lin, et al.. (2022). Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer. Oncogene. 41(23). 3210–3221. 26 indexed citations
3.
Zhang, Zhiyuan, Guodong He, Yang Lv, et al.. (2022). HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer. Cell Death and Disease. 13(1). 74–74. 26 indexed citations
4.
Mao, Yihao, Yuqiu Xu, Chang Jiang, et al.. (2022). The immune phenotypes and different immune escape mechanisms in colorectal cancer. Frontiers in Immunology. 13. 968089–968089. 15 indexed citations
5.
Lv, Yang, Qingyang Feng, Zhiyuan Zhang, et al.. (2022). Low ferroptosis score predicts chemotherapy responsiveness and immune‐activation in colorectal cancer. Cancer Medicine. 12(2). 2033–2045. 19 indexed citations
6.
Xu, Pingping, Yang Lv, Zhengchuan Niu, et al.. (2022). Faster postoperative recovery by robotic-assisted surgery in elderly patients with sigmoid colon and rectal cancer. SHILAP Revista de lepidopterología. 1(1). 100007–100007. 1 indexed citations
7.
Xu, Yuqiu, Qingyang Feng, Yijiao Chen, et al.. (2021). Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study. Cancer Management and Research. Volume 13. 1087–1097. 2 indexed citations
8.
Zhang, Zhiyuan, Meiling Ji, Yang Lv, et al.. (2020). A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I–III rectal cancer. Genomics. 112(5). 3274–3283. 9 indexed citations
9.
Zhang, Zhiyuan, Qingyang Feng, Peng Zheng, et al.. (2020). Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer. Genomics. 112(6). 4032–4040. 12 indexed citations
10.
Lv, Yang, Qingyang Feng, Ye Wei, et al.. (2020). Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. SHILAP Revista de lepidopterología. 10(3). e121–e121. 12 indexed citations
11.
12.
Han, Xu, Wenqi Chen, Pingping Chen, et al.. (2020). Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas. 49(4). 514–523. 14 indexed citations
13.
14.
15.
Zhang, Lei, Yang Lv, Yefei Rong, et al.. (2019). <p>Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis</p>. OncoTargets and Therapy. Volume 12. 1007–1020. 11 indexed citations
16.
Lv, Yang, Qingyang Feng, Yihao Mao, et al.. (2019). <p>Exploration of exact significance of lymph node ratio and construction of a novel stage in colon cancer with no distant metastasis</p>. Cancer Management and Research. Volume 11. 6841–6854. 7 indexed citations
17.
18.
19.
Pu, Ning, Shanshan Gao, Guochao Zhao, et al.. (2017). Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection. Journal of Cancer. 8(16). 3362–3370. 38 indexed citations
20.
Lv, Yang, Xu Han, Chunyan Zhang, et al.. (2017). Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs. Endocrine Connections. 7(1). 169–178. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Smiroldo Breakdown of academic impact, for papers by Shuichi Tsukamoto Breakdown of academic impact, for papers by Isabella Bergagnini Breakdown of academic impact, for papers by Hirofumi Rokutan Breakdown of academic impact, for papers by Ryo Muranushi Breakdown of academic impact, for papers by Chenghao Yi Breakdown of academic impact, for papers by Akira Okimura Breakdown of academic impact, for papers by Fenglong Bie Breakdown of academic impact, for papers by J.C. Ruffinelli
Rankless by CCL
2026